Full Text
Analysis Of Eribulin Mesylate Dosing Modifications Impact On Administration Persistence In Patients With Metastatic Breast Cancer (Mbc)

Abstract

Authors

BA Feinberg J Drenning DF Garofalo L Lal J Montgomery

Back to Volume 18, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×